2 results
Approved WMOCompleted
This is an exploratory study to assess changes in colonic inflammation after 8 weeks of treatment with tofacitinib (XELJANZ) 2 x 5 mg BID in patients with moderate to severely active UC.
Approved WMOCompleted
The aim of this study is to investigate the use of spirometry, forced oscillation technique (FOT), and negative expiratory pressure (NEP) in both protrusion and retraction of the mandible as prediction measurements for MAD success.